Penciclovir
Back to searchMolecule Structure
Scientific Name
Penciclovir
Description of the Drug
Penciclovir is a topical nucleoside polymerase inhibitor used in the treatment of recurrent herpes labialis.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00299
http://www.drugbank.ca/drugs/DB00299
Brand Name(s)
Denavir, Fenistil, Vectavir
Company Owner(s)
Mylan Pharmaceuticals Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Human herpesvirus 1 DNA polymerase | SINGLE PROTEIN | INHIBITOR | CHEMBL1872 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL3494 | SCHEMBL19236307 |
| PharmGKB | PA450839 | |
| Human Metabolome Database | HMDB0014444 | |
| DrugBank | DB00299 | |
| PubChem: Thomson Pharma | 15122289 | 14774399 |
| PubChem | 135398748 | |
| LINCS | LSM-5587 | |
| Nikkaji | J228.035C | |
| PDBe | PE2 | |
| BindingDB | 50210804 | |
| EPA CompTox Dashboard | DTXSID9046491 | |
| DrugCentral | 2079 | |
| Brenda | 112860 | |
| ChemicalBook | CB7731886 | |
| rxnorm | DENAVIR | PENCICLOVIR |
| PubChem: Drugs of the Future | 12013576 | |
| KEGG Ligand | C07417 | |
| ChEBI | 7956 | |
| ZINC | ZINC000000001899 |
